pp32r1 controls the decay of the RNA-binding protein HuR

Oncology Reports

Volumn 31, Issue 3, 2014, Pages 1103-1108

  Imamachi, Kenji ^a   Higashino, Fumihiro ^a   Kitamura, Tetsuya ^a   Kakuguchi, Wataru ^a   Yanagawa Matsuda, Aya ^a   Ishikawa, Makoto ^a   Kitagawa, Yoshimasa ^a   Totsuka, Yasunori ^a   Shindoh, Masanobu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

AU rich element; Decay; HuR; pp32; pp32r1

Indexed keywords

CASPASE 3; HUR PROTEIN; PP32R1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELL STRESS; CELL SURVIVAL; CELLULAR DISTRIBUTION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

CASPASE 3; GENE EXPRESSION; HEK293 CELLS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEOLYSIS; STRESS, PHYSIOLOGICAL;

EID: 84896697381     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2956     Document Type: Article

References (24)

1. Matsuoka K, Taoka M, Satozawa N, et al: A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons. Proc Natl Acad Sci USA 91: 9670-9674, 1994.
2. Chen TH, Brody JR, Romantsev FE, et al: Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci. Mol Biol Cell 12: 2045-2056, 1996.
3. Kadkol SS, Brody JR, Pevsner J, Bai J and Pasternack GR: Modulation of oncogenic potential by alternative gene use in human prostate cancer. Nat Med 5: 275-279, 1999.
4. Kadkol SS, El Naga GA, Brody JR, et al: Expression of pp32 gene family members in breast cancer. Breast Cancer Res Treat 68:65-73, 2001.
5. Pan W, da Graca LS, Shao Y, Yin Q, Wu H and Jiang X: PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis. J Biol Chem 284: 6946-6954, 2009.
6. Adegbola O and Pasternack G: Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. J Biol Chem 280: 15497-15502, 2005.
7. Matilla A, Koshy BT, Cummings CJ, Isobe T, Orr HT and Zoghbi HY: The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389: 974-978, 1997.
8. Beresford PJ, Kam CM, Powers JC and Lieberman J: Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci USA 94: 9285-9290, 1997.
9. Brennan CM, Gallouzi IE and Steitz JA: Protein ligands to HuR modulate its interaction with target mRNA in vivo. J Cell Biol 151: 1-14, 2000.
10. Gallouzi IE, Brennan CM and Steitz JA: Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. RNA 7: 1348-1361, 2001.
11. Ma WJ, Cheng S, Campbell C, Wright A and Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 99: 8144-8151, 1996.
12. Hinman MN and Lou H: Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65: 3168-3181, 2008.
13. Lopez de Silanes I, Lai A and Gorospe M: HuR: post-transcriptional paths to malignancy. RNA Biol 2: 11-13, 2005.
14. López de Silanes I, Fan J, Yang X, et al: Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22: 7146-7154. 2003.
15. Srikantan S and Gorospe M: HuR function in disease. Front Biosci 17: 189-205, 2012.
16. Higashino F, Aoyagi M, Takahashi A, et al: Adenovirus E4orf6 targets pp32/LANP to control the fate of ARE-containing mRNA by perturbing the CRM1-dependent mechanism. J Cell Biol 170: 15-20, 2005.
17. Kuroshima T, Aoyagi M, Yasuda M, et al: Viral-mediated stabilization of AU-rich element containing mRNA contributes to cell transformation. Oncogene 30: 2912-2920, 2011.
18. Hasegawa H, Kakuguchi W, Kuroshima T, et al: HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells. Br J Cancer 100: 1943-1948, 2009.
19. Kakuguchi W, Kitamura T, Kuroshima T, et al: HuR knockdown chanaes the oncogenic potential of oral cancer cells. Mol Cancer Res 8: 520-528, 2010.
20. Mazroui R, Di Marco S, Clair E, et al: Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J Cell Biol 180: 113-127, 2008.
21. Weigel S and Dobbelstein M: The nuclear export signal within the E4orf6 protein of adenovirus type 5 supports virus replication and cytoplasmic accumulation of viral mRNA. J Virol 74: 764-772, 2000.
22. Aoyagi M, Higashino F, Yasuda M, et al: Nuclear export of the adenovirus E4orf6 protein is necessary for its ability to antagonize the apoptotic activity of the BH3-only proteins. Oncogene 22: 6919-6927, 2003.
23. Higashino F, Pipas JM and Shenk T: Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proc Natl Acad Sci USA 95: 15683-15687, 1998.
24. Buddaseth S, Göttmann W, Blasczyk R, et al: Dysregulation of cell cycle caused by overexpression of the oncogene pp32r1 (ANP32C) and the Tyr>His mutant pp32r1Y140H. Biochim Biophys Acta 1833: 1212-1221, 2013.